Evidence map›Paper›PMID 37033892›Full record

ReviewWorld journal of psychiatry2023

Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.

Susan Young, Cyrus Abbasian, Zainab Al-Attar, Polly Branney, Bill Colley, Samuele Cortese, Sally Cubbin, Quinton Deeley, Gisli Hannes Gudjonsson, Peter Hill and 12 more

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  6. Diagnosis and Treatment of ADHD in the Pediatric Population.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Susan YoungDepartment of Psychology, Psychology Services Limited, Croydon CR9 7AE, United Kingdom.
Cyrus AbbasianPsychiatry-UK Limited, Cornwall PL33 9ET, United Kingdom.
Zainab Al-AttarPsychiatry-UK Limited, Cornwall PL33 9ET, United Kingdom.
Polly BranneyADHD and Autism, Oxford ADHD & Autism Centre, Headington OX3 7BX, United Kingdom.
Bill ColleyCLC Consultancy, Dunkeld PH8 0AY, United Kingdom.
Samuele CorteseCenter for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.
Sally CubbinAdult ADHD, Adult ADHD Clinic Ltd, Oxford OX3 7RP, United Kingdom.
Quinton DeeleyForensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology & Neuroscience, King's College London Institute of Psychiatry, London SE5 8AF, United Kingdom.
Gisli Hannes GudjonssonDepartment of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, United Kingdom.
Peter HillDepartment of Psychiatry, University of London, London WC1E 7HU, United Kingdom.
Jack HollingdaleDepartment of Psychology, Compass Psychology Services Ltd, London BR1 9DX, United Kingdom.
Steve JendenBirribi Ltd, Narberth SA67 7DU, United Kingdom.
Joe JohnsonHalton and Knowsley Adult ADHD Team, Merseycare NHS Foundation Trust, Winwick WA2 9WA, United Kingdom.
Deborah JudgeBirribi Ltd, Narberth SA67 7DU, United Kingdom.
Alexandra LewisDepartment of Psychiatry, Fulbourn Hospital, Cambridge CB21 5EF, United Kingdom.
Peter MasonDepartment of Psychiatry, Dr Peter Mason ADHD & Psychiatry Services Limited, Liverpool L1 9AR, United Kingdom.
Raja MukherjeeAdult Neurodevelopmental Service, Horizon House, Epsom KT17 4QJ, United Kingdom.
David NuttDepartment of Psychiatry, Imperial College London, London WS12 0NN, United Kingdom.
Jane RobertsService User Representative, Gloucestershire GL1 3NN, United Kingdom.
Fiona RobinsonDrug & Alcohol Services, Surrey & Borders Partnership Trust, Leatherhead KT22 7AD, United Kingdom.
Emma WoodhouseForensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, United Kingdom.
Kelly CocallisWansbeck General Hospital, Northumbria Healthcare NHS Foundation Trust, Ashington NE63 9JJ, United Kingdom.
King's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attention-deficit/hyperactivity disorder (ADHD) often co-occurs with substance use (SU) and/or substance use disorder (SUD). Individuals with concurrent ADHD and SU/SUD can have complex presentations that may complicate diagnosis and treatment. This can be further complicated by the context in which services are delivered. Also, when working with young people and adults with co-existing ADHD and SU/SUD, there is uncertainty among healthcare practitioners on how best to meet their needs. In February 2022, the United Kingdom ADHD Partnership hosted a meeting attended by multidisciplinary experts to address these issues. Following presentations providing attendees with an overview of the literature, group discussions were held synthesizing research evidence and clinical experience. Topics included: (1) A review of substances and reasons for use/misuse; (2) identification, assessment and treatment of illicit SU/SUD in young people and adults with ADHD presenting in community services; and (3) identification, assessment and treatment of ADHD in adults presenting in SU/SUD community and inpatient services. Dis-cussions highlighted inter-service barriers and fragmentation of care. It was concluded that a multimodal and multi-agency approach is needed. The consensus group generated a table of practice recommendations providing guidance on: identification and assessment; pharmacological and psychological treatment; and multi-agency interventions.

Indexed as

AssessmentAttention-deficit/hyperactivity disorderComorbidityPharmacokineticsSubstance useTreatment

Identifiers

PMID37033892
PMCPMC10075023
OpenAlexW4327566532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.